CRISPR-Cas9 Genomic Editing as an Innovation in the Management of Sickle Cell Disease: A Systematic Review. American Journal of Medical Science and Innovation, [S. l.], v. 2, n. 2, p. 44–56, 2023. DOI: 10.54536/ajmsi.v2i2.1760. Disponível em: https://e-pallipublishers.com/index.php/ajmsi/article/view/1760. Acesso em: 8 may. 2026.